<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> with <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e> is a state of sympathetic nerve <z:hpo ids='HP_0000752'>hyperactivity</z:hpo>, which can develop subsequently in non-diabetic first-degree offspring of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Although both type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and sympathetic activation are major <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e>, the level of sympathetic nerve activity is as yet unknown in offspring of type 2 diabetic patients who are ostensibly <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>We therefore sought to quantify sympathetic nerve activity and its relationship to plasma insulin levels in ostensibly <z:mpath ids='MPATH_458'>normal</z:mpath> offspring of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, relative to a matched <z:mpath ids='MPATH_458'>normal</z:mpath> control group with no family history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>SUBJECTS AND METHODS: In two closely matched groups comprising 23 non-diabetic offspring of type 2 diabetic patients and 23 <z:mpath ids='MPATH_458'>normal</z:mpath> control individuals we measured resting muscle sympathetic nerve activity (MSNA) as the mean frequency of multi-unit bursts of MSNA and single units of MSNA (s-MSNA) with defined vasoconstrictor properties </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In offspring of type 2 diabetic patients, the fasting plasma levels of insulin (7.4+/-0.80 microU/ml) and s-MSNA (45+/-3.2 impulses/100 beats) were greater (p&lt;0.009 and p&lt;0.003) than those in control persons (4.6+/-0.76 microU/ml and 32+/-3.1 impulses/100 beats, respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>MSNA bursts and derived <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> followed similar trends </plain></SENT>
<SENT sid="6" pm="."><plain>Sympathetic nerve activity was significantly correlated to insulin levels (p&lt;0.0002) and resistance (p&lt;0.0001) in offspring of type 2 diabetic patients, but not in control subjects </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS/INTERPRETATION: Sympathetic activation occurred in <z:mpath ids='MPATH_458'>normal</z:mpath> non-diabetic offspring of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in proportion to their plasma insulin levels </plain></SENT>
<SENT sid="8" pm="."><plain>Our data indicate the presence of a mechanistic link between <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e> and sympathetic activation, both of which could play a role in the subsequent development of <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
</text></document>